Papers: 10.1186/s13046-018-0702-x

https://doi.org/10.1186/s13046-018-0702-x

Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations

Cited by: 51
Author(s): Matteo Allegretti, Alessandra Fabi, Simonetta Buglioni, Aline Martayan, Laura Conti, Edoardo Pescarmona, Gennaro Ciliberto, Patrizio Giacomini
Published: over 7 years ago

Software Mentions 1